选择性雌激素受体调节剂 - Suppr

Suppr

超能文献

Selective estrogen receptor modulators.

作者信息

Bryant Henry U

机构信息

Lilly Research Laboratories, Indianapolis IN, USA.

出版信息

Rev Endocr Metab Disord. 2002 Sep;3(3):231-41. doi: 10.1023/a:1020076426727.

DOI:10.1023/a:1020076426727

PMID:12215718

Abstract

摘要

相似文献

Selective estrogen receptor modulators.

Rev Endocr Metab Disord. 2002 Sep;3(3):231-41. doi: 10.1023/a:1020076426727.

Antiestrogens and selective estrogen receptor modulators as multifunctional medicines. 1. Receptor interactions.

J Med Chem. 2003 Mar 13;46(6):883-908. doi: 10.1021/jm020449y.

[Selective estrogen receptor modulators].

Pharm Unserer Zeit. 2004;33(5):357-9. doi: 10.1002/pauz.200400081.

Antiestrogens and selective estrogen receptor modulators as multifunctional medicines. 2. Clinical considerations and new agents.

J Med Chem. 2003 Mar 27;46(7):1081-111. doi: 10.1021/jm020450x.

Structure-based approach for the discovery of novel selective estrogen receptor modulators.

Curr Med Chem. 2011;18(8):1188-94. doi: 10.2174/092986711795029645.

m-Carborane bisphenol structure as a pharmacophore for selective estrogen receptor modulators.

Bioorg Med Chem Lett. 2006 Aug 1;16(15):3943-6. doi: 10.1016/j.bmcl.2006.05.032. Epub 2006 Jun 2.

Selective estrogen receptor modulator medicinal chemistry at Merck. A review.

Curr Top Med Chem. 2008;8(9):792-812. doi: 10.2174/156802608784535066.

Tetrahydroquinoline-based selective estrogen receptor modulators (SERMs).

Bioorg Med Chem Lett. 2003 Jun 2;13(11):1907-10. doi: 10.1016/s0960-894x(03)00306-8.

COMP-structure-based design and development of estrogen receptor modulators.

IDrugs. 2006 Nov;9(11):748-50.

Structure-activity relationships of SERMs optimized for uterine antagonism and ovarian safety.

Bioorg Med Chem Lett. 2007 Jul 1;17(13):3544-9. doi: 10.1016/j.bmcl.2007.04.044. Epub 2007 Apr 24.

引用本文的文献

Novel Advances in the Role of Selective Estrogen Receptor Modulators in Hormonal Replacement Therapy: A Paradigm Shift.

Cureus. 2023 Nov 19;15(11):e49079. doi: 10.7759/cureus.49079. eCollection 2023 Nov.

Triaryl-substituted Schiff bases are high-affinity subtype-selective ligands for the estrogen receptor.

J Med Chem. 2014 Apr 24;57(8):3532-45. doi: 10.1021/jm500268j. Epub 2014 Apr 7.

Invasive lobular carcinoma cell lines are characterized by unique estrogen-mediated gene expression patterns and altered tamoxifen response.

Cancer Res. 2014 Mar 1;74(5):1463-74. doi: 10.1158/0008-5472.CAN-13-2779. Epub 2014 Jan 14.

The role of oestrogen and other hormones in the pathophysiology and treatment of schizophrenia.

Schizophr Res Treatment. 2012;2012:540273. doi: 10.1155/2012/540273. Epub 2012 Feb 19.

Role of estrogen treatment in the management of schizophrenia.

CNS Drugs. 2012 Jul 1;26(7):549-57. doi: 10.2165/11630660-000000000-00000.

Prediction of binding affinity for estrogen receptor alpha modulators using statistical learning approaches.

Mol Divers. 2008 May;12(2):93-102. doi: 10.1007/s11030-008-9080-1. Epub 2008 Jul 26.

本文引用的文献

Effects of raloxifene on bone density, biomarkers, and histomorphometric and biomechanical measures in ovariectomized cynomolgus monkeys.

Menopause. 2002 Sep-Oct;9(5):320-8. doi: 10.1097/00042192-200209000-00004.

Selective estrogen receptor modulators: tissue selectivity and differential uterine effects.

Climacteric. 1999 Dec;2(4):268-83. doi: 10.3109/13697139909038087.

Arzoxifene, a new selective estrogen receptor modulator for chemoprevention of experimental breast cancer.

Cancer Res. 2001 Dec 1;61(23):8412-5.

Effect of raloxifene on serum triglycerides in postmenopausal women: influence of predisposing factors for hypertriglyceridemia.

Clin Ther. 2001 Sep;23(9):1552-65. doi: 10.1016/s0149-2918(01)80127-2.

Levormeloxifene prevents increased bone turnover and vertebral bone loss following ovariectomy in cynomolgus monkeys.

Bone. 2001 Jul;29(1):7-15. doi: 10.1016/s8756-3282(01)00465-3.

Effects of raloxifene and hormone replacement therapy on markers of serum atherogenicity in healthy postmenopausal women.

Maturitas. 2001 Jul 25;39(1):71-7. doi: 10.1016/s0378-5122(00)00224-3.

Raloxifene effect on frequency of surgery for pelvic floor relaxation.

Obstet Gynecol. 2001 Jul;98(1):91-6. doi: 10.1016/s0029-7844(01)01390-4.

Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results from the MORE trial. Multiple outcomes of raloxifene evaluation.

Breast Cancer Res Treat. 2001 Jan;65(2):125-34. doi: 10.1023/a:1006478317173.

The effect of raloxifene on coronary arteries in aged ovariectomized ewes.

J Vet Pharmacol Ther. 2000 Jun;23(3):175-9. doi: 10.1046/j.1365-2885.2000.00270.x.

Prevention of bone loss by EM-800 and raloxifene in the ovariectomized rat.

J Steroid Biochem Mol Biol. 2000 Sep;74(1-2):45-56. doi: 10.1016/s0960-0760(00)00087-x.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验